Preventing PTSD after a car crash with a dissolving tablet
Part of Mental health clinical trials.
This study tests a dissolving tablet (cyclobenzaprine) placed under the tongue to see if it can help prevent PTSD and reduce pain symptoms after a car accident. You would take the medication for 14 days and be followed for about 8 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were in a car accident within the last 3 days and are now in the emergency room.
- You are between 18 and 55 years old.
- You have a smartphone and email that you check regularly.
- Your pain level is at least 4 out of 10.
- You are not pregnant, breastfeeding, or planning pregnancy, and if you could become pregnant, you agree to use effective birth control for the first 21 days.
- You do not have certain heart problems, liver or kidney issues, or take specific medications (like some antidepressants or painkillers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called BXCL501 to see if it helps people recover from stress after a motor vehicle crash. You can join if you went to the emergency room within 3 days of the crash and are expected to go home.
This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.
This study tests a brain stimulation method to help prevent PTSD in people who recently experienced a traumatic event and have high stress symptoms. It aims to build resilience and reduce the risk of long-term PTSD.
This study tests a remote therapy program to help people who have been in a car accident and are at risk for PTSD. The goal is to see if improving sleep soon after a trauma can prevent PTSD symptoms.
This study tests a combination of a single magnetic brain stimulation session (TMS) and a medication called D-cycloserine (DCS), which may help strengthen positive memories and reduce post-traumatic stress disorder (PTSD) symptoms. It is designed for first responders who have been diagnosed with PTSD and are currently taking stable medications.
This trial tests a new oral medication, PT150, to see if it helps reduce PTSD symptoms in veterans. You must have had PTSD for at least 3 months and not be taking certain other medications.
Hear when a new Acute Stress Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.